CKM and neoplasm: Interestingly, in cancer, microbial dysregulation promotes chronic inflammation and tumor progression; TMAO, FMO3, lipopolysaccharides (LPS), and short-chain fatty acids (SCFA) influence immune responses, linking gut microbiota alterations to CKM-related complications and oncogenic risks [107].